Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
8.47
-0.10 (-1.17%)
Mar 10, 2025, 12:32 PM EST - Market open
Treace Medical Concepts Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Treace Medical Concepts stock have an average target of 9.07, with a low estimate of 7.00 and a high estimate of 14.5. The average target predicts an increase of 7.08% from the current stock price of 8.47.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Treace Medical Concepts stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 6 | 6 | 7 | 7 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 8 | 8 | 8 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Hold Maintains $8.4 → $10 | Hold | Maintains | $8.4 → $10 | +18.06% | Mar 3, 2025 |
Lake Street | Lake Street | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +71.19% | Dec 31, 2024 |
Truist Securities | Truist Securities | Hold Maintains $7 → $8.4 | Hold | Maintains | $7 → $8.4 | -0.83% | Dec 18, 2024 |
JP Morgan | JP Morgan | Hold Initiates $8 | Hold | Initiates | $8 | -5.55% | Dec 17, 2024 |
Stifel | Stifel | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | -5.55% | Nov 6, 2024 |
Financial Forecast
Revenue This Year
230.19M
from 209.36M
Increased by 9.95%
Revenue Next Year
253.57M
from 230.19M
Increased by 10.16%
EPS This Year
-0.76
from -0.90
EPS Next Year
-0.66
from -0.76
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 240.6M | 275.1M | 272.4M |
Avg | 230.2M | 253.6M | 264.6M |
Low | 219.1M | 234.8M | 254.2M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 14.9% | 19.5% | 7.4% |
Avg | 10.0% | 10.2% | 4.3% |
Low | 4.7% | 2.0% | 0.3% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.70 | -0.49 |
Avg | -0.76 | -0.66 |
Low | -0.86 | -0.74 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.